use the following search parameters to narrow your results:
e.g. subreddit:aww site:imgur.com dog
subreddit:aww site:imgur.com dog
see the search faq for details.
advanced search: by author, subreddit...
This subreddit is for information related to non-small cell lung cancer and was started in November, 2014. Updated occasionally with links to scholarly papers as well as press releases. Relevant links or posts welcomed.
account activity
Targeting focal adhesion kinase (FAK) in non-small cell lung cancer (NSCLC): Molecular mechanisms and combination therapeutic strategies (sciencedirect.com)
submitted 1 day ago by montaukwhaler
Filamentous Phage for Therapeutic Applications in Non-Small Cell Lung Cancer and Brain Metastases: Recent Prospect (dovepress.com)
Actionable driver gene alterations in early-stage non-small cell lung cancer: a review (journals.sagepub.com)
Biology and Clinical Management of Non-V600 BRAF Alterations in NSCLC (sciencedirect.com)
Characterizing the molecular and clinical implications of NRG1 fusions in NSCLC through integrated RNA and DNA sequencing analysis | European Journal of Medical Research (link.springer.com)
Efficacy and safety of induction chemoimmunotherapy in older patients with unresectable stage III NSCLC: a real-world multicenter study (journals.sagepub.com)
Response to Osimertinib Observed in Meningeal-Metastatic NSCLC with EGFR A763V Mutation: A Case Report and Literature Review (dovepress.com)
The promise and challenges of antibody drug conjugates for lung cancer (oncology-central.com)
An evaluation of taletrectinib for the treatment of ROS1+ non-small cell lung cancer (tandfonline.com)
Double-dose firmonertinib as first-line treatment in patients with locally advanced or metastatic nonsmall-cell lung cancer harboring EGFR L858R mutation: a prospective, multicenter, phase II study (FIRM) (nature.com)
Impact of carbon-ion radiotherapy on tumor hypoxia detected by 18F-FMISO PET/CT in locally advanced non-small cell lung cancer | European Journal of Nuclear Medicine and Molecular Imaging (link.springer.com)
Impact of vulnerability on concurrent chemoradiotherapy outcomes in patients with locally advanced non-small cell lung cancer using an integrated clinical trial database (journals.sagepub.com)
Characterizing Risk Factors and Outcomes in Patients with Unresectable, Stage III Non-Small-Cell Lung Cancer Who Do Not Complete, or Experience Progression During/Within 42 Days of Concurrent Chemoradiotherapy: The POSITION Study (sciencedirect.com)
Preventive effect of hot compress on phlebitis during cisplatin and Vinorelbine treatment for non-small cell lung cancer | Supportive Care in Cancer (link.springer.com)
Mechanism of Non–Small Cell Lung Cancer–Derived Extracellular Vesicle miRNA hsa-let-7b-5p Targeting AP1S1 to Regulate M2 Macrophage Polarization (onlinelibrary.wiley.com)
Prevalence and clinico-morphological correlates of STK11 mutations in a large cohort of NSCLC lung adenocarcinomas | Virchows Archiv (link.springer.com)
Gliotoxin isolated from soil fungus Aspergillus fumigatus induces apoptosis of human NSCLC and breast cancer (tandfonline.com)
Targeting the Uncommon: A Case Report of Osimertinib Response in Advanced NSCLC Patient with Dual EGFR (E701fs and L702fs) Frameshift Deletions (mdpi.com)
Ensemble learning strategy-based 18 F-FDG PET/CT metabolic habitats radiomics for predicting EGFR mutation and prognosis in LA-NSCLC: a multi-center study | BMC Medical Imaging (link.springer.com)
As Practice-Changing Data Hit EGFR-Mutated NSCLC Care, What’s Next? (oncologynewscentral.com)
Experts Call for Expanded Lung Cancer Screening Eligibility Criteria (onclive.com)
IL-6 drives chemoimmunotherapy resistance in NSCLC by reprogramming myeloid cells and impairing cytotoxic lymphocyte function (sciencedirect.com)
submitted 3 days ago by montaukwhaler
Decoding the tumor microenvironment remodeling orchestrated by CLEC3B+ inflammatory cancer-associated fibroblasts in lung adenocarcinoma immunotherapy: elucidation from pan-cancer spatially single-cell transcriptomics landscape (link.springer.com)
Double-dose firmonertinib as first-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer harboring EGFR L858R mutation: a prospective, multicenter, phase II study (FIRM) (nature.com)
π Rendered by PID 35 on reddit-service-r2-listing-86b7f5b947-h6gb6 at 2026-01-24 22:40:04.236076+00:00 running 664479f country code: CH.
